| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| 2NV | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 1 | 1 | crystallization |
| P3G | 3,6,9,12,15-pentaoxaheptadecane | 1 | 1 | crystallization |
| P3G | 3,6,9,12,15-pentaoxaheptadecane | 2 | 2 | other |
| 6JZ | 3,6,9,12,15-pentaoxaheptadecane | 2 | 2 | other |
| P33 | 3,6,9,12,15,18-hexaoxaicosane-1,20-diol | 3 | 3 | crystallization |
| PE8 | 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol | 1 | 1 | crystallization |
| PE5 | 3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol | 1 | 1 | crystallization |
| XPE | 3,6,9,12,15,18,21,24,27-nonaoxanonacosane-1,29-diol | 1 | 1 | crystallization |
| 175 | 3,5-dihydro-5-methylidene-4h-imidazol-4-on | 481 | 350 | other |
| 175 | 3,5-dihydro-5-methylidene-4h-imidazol-4-on | 103 | 81 | biological |
| QUE | 3,5,7,3',4'-pentahydroxyflavone | 1 | 1 | crystallization |
| CPS | 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfona te | 2 | 2 | crystallization |
| NXL | (2s,5r)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carbox amide | 1 | 1 | biological |
| ZD2 | (2s)-4-(6-amino-9h-purin-9-yl)-2-hydroxybutanoic acid | 1 | 1 | biological |
| LMR | (2s)-2-hydroxybutanedioic acid | 1 | 1 | biological |
| LMR | (2s)-2-hydroxybutanedioic acid | 2 | 1 | other |
| LMR | (2s)-2-hydroxybutanedioic acid | 1 | 1 | crystallization |
| 0RV | (2s)-2-[(1s,2r)-1-carboxy-2-hydroxypropyl]-4-{[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-2h-pyrrole-5-carboxylic acid | 1 | 1 | biological |
| PNK | (2r,4s)-2-{(r)-carboxy[(phenylacetyl)amino]methyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 1 | 1 | biological |
| HIW | (2r,4s)-2-[(1s,2r)-1-carboxy-2-hydroxypropyl]-4-[(2-{[( z)-iminomethyl]amino}ethyl)sulfanyl]-3,4-dihydro-2h-pyr role-5-carboxylic acid | 1 | 1 | biological |